DiagNano Frequently Asked Questions (FAQ)
Who are DiagNano's competitors?
Competitors of DiagNano include DermTech International and 4 more.
Compare DiagNano to Competitors
Sidec Technologies enables visualization of cellular events in 3-D at the molecular level
J. Lamarck is a company that offers advisory services to private individuals, companies and pension funds who want to invest in the biotechnology sector.nThe company offers a high quality service and its analyst provide professional assistance to people who want to diversify a part of their portfolio in this emerging industry. Because of the nature of biotechnology investments, the company believe it is important that users work with specialists to define their portfolio strategy. Generally, specialists do things better.nOver the next few years the company will be witness of astonishing progress in health care and medicine, the company will be able to fight and cure diseases like AIDS and cancer finally. The company will also find solutions to clean up the environment and new crops that don't need pesticide. These new products will obviously boost the visibility of the companies that were at the beginning of this process on the stock market and consequently create great opportunity for it's shareholders.nJ. Lamarck wants to be their partner in this great venture.
Punjab Biotechnology Incubator is a professional society focused on biotechnology incubation and analytical services within the biotechnology sector. The company offers a range of services including environmental testing, food safety analysis, water quality assessment, and validation of pharmaceutical and AYUSH products. It primarily serves sectors such as agriculture, environment, and pharmaceuticals. It is based in India.
Iverson Genetic Diagnostics offers advanced genetic testing to health care providers to promote early disease detection and to help physicians achieve optimal dosing of critical medications. The company develops genetic tests that aims to become the model for disease detection and informed treatment, ushering in a new era of predictive, preventative and affordable health care.
Woomera was started in June of 2003 to bring science developed at Dartmouth Medical School from the lab to the clinic in the form of treatments and diagnostic tools for various cancers. Woomera is a biopharmaceutical company developing immuno-products targeting markers for the treatment of specific cancers. The Woomera technology platform aims to build upon 30 years of research by Dr. William G. North, Professor of Physiology at Dartmouth Medical School. The company opened offices in Lebanon, NH in November of 2004. In February of 2005, the company added Dr. Lyn Oligino, Ph.D. to the staff.
Dr. Alex Waldrop has developed AcriGlow-301TM to detect the presence of hydrogen peroxide by chemilumniescence for medical and environmental purposes. The European patent has issued for this chemiluminescent technology developed with co-inventor Dr. Calvin Vary of MMCRI (Maine Medical Center Research Institute). Used as a detection system, the process can be adapted to detect a wide variety of substances. Developed with support of MMCRI, Jane Havey of Capricorn Products and the Maine Center for Innovation and Biotechnology (CIBT, the predecessor to MTI), Dr Waldrop hopes to license the technology to clients in the fields of bio-technology and environmental detection. Various companies in the United States, in Japan and in Spain have used the product on a trial basis. The U.S. patent is still pending. This technology has been applied to antibody-based diagnostics.